Life-Sciences-Germany.com
The Life Sciences Web Portal for German-speaking Europe

This is a free web portal for the life sciences in German-speaking Europe... » read more

ECBF Leads €10m Series B of EFOS d.o.o. (Trapview) (2022-09-20)
> With its AI-based solution for insect monitoring and forecasting, Trapview helps reduce the use of pesticides and promotes more sustainable agricultural practices. > With this investment, the European Circular Bioeconomy Fund (ECBF) supports a European champio...
Nuvisan: $9.6m for Non-hormonal Contraceptive Medicines (2022-09-20)
NUVISAN’s integrated drug discovery expertise leveraged in a grant from the Bill & Melinda Gates Foundation NUVISAN ICB GmbH, a fully integrated contract research service provider for drug discovery and development (“NUVISAN ICB”), announced today that the com...
Scailyte Closes Series CHF6m Series A Funding (2022-09-19)
> Scailyte has successfully finished the Series A funding raising CHF 6 million from a Swiss family office, Mirabaud bank and previous investors. > Peter Ibbotson, who has recently been promoted to the position of a Partner at Swisscom Ventures will replace Domi...
Tricares Raises €47m Series C Financing Round (2022-09-15)
TRiCares SAS (“TRiCares”) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, is pleased to announce today that it has successfully raised €47m from the first closing of its Series C financing round. The completion of t...
Aignostics’ €14m Series A Led by Wellington Partners (2022-09-15)
> Oversubscribed financing round with top-tier life science investors, led by Wellington Partners > Spin-off from Charité – Universitätsmedizin Berlin developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseases > F...
Capstan Therapeutics Launches with $165m in Funding (2022-09-14)
> Capstan’s foundation is built on research developed by world-renowned mRNA and cell therapy scientists and clinicians at the University of Pennsylvania > Therapy development focused on cell type-specific engineering across oncology, autoimmune disease, blood d...
Heidelberg Pharma: Takeda Exercises License Option for ATAC (2022-09-09)
Heidelberg Pharma AG (FSE: HPHA) today announced that its subsidiary Heidelberg Pharma Research GmbH and Takeda signed a license agreement granting Takeda an exclusive license to commercially develop an Antibody Targeted Amanitin Conjugate directed to a previously ...
faCellitate Closes €3.7m Seed Round Led by Sarstedt & HTGF (2022-09-07)
> Proprietary intelligent polymer surface coating platform enables development of first-in-class lab materials for modern cell culture applications > Closing of seed round completed raising €3.7 million from SARSTEDT, High-Tech Gründerfonds (HTGF), R3 Consulting...
Indivumed & CellPhenomics Announce Partnership (2022-09-07)
European Union-Funded Project to Result in Novel Treatment Approaches for Several Solid Tumor Types Indivumed GmbH (“Indivumed”) and CELLphenomics GmbH (“CELLphenomics”) today announced a partnership to create a unique platform for faster and more efficient di...
QLi5 Therapeutics Attracts €10m in Series A Financing (2022-09-07)
Development of Novel Proteasome Inhibitors for treating cancer, inflammatory and autoimmune disorders Qli5 Therapeutics GmbH (QLi5), a German-Korean joint venture developing a new class of proteasome inhibitors, has closed a EUR 10 million series A financing r...

» Show all News!

Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!

[LSG] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Germany, Austria and Switzerland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!

» Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)